First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...
Washington — The federal government has begun the process of exempting the nation’s first purpose-built robotaxi from certain safety standards so it can deploy commercially on American roads.
WINOOSKI — Students and families from across Vermont are invited to the Davis Center at the University of Vermont (UVM) for College & Career Pathways on Saturday, March 14. Organized by VSAC, College ...
Registration: Free but required. Register here. VSAC’s expert outreach counselors and other professionals from around the region will offer workshops to help families navigate the college and career ...
The MarketWatch News Department was not involved in the creation of this content. -- Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated ...
Stroke patients face unequal access to clot-removal care; race and insurance shape transfers, even with Medicare—here’s what must change, according to Luke Messac, MD, PhD. Disparities in access to ...
Complement-mediated hemolytic uremic syndrome (CM-HUS), commonly referred to as atypical HUS, is a rare thrombotic microangiopathy caused by uncontrolled activation of the alternative complement ...
Many novel treatment approaches are being investigated to halt progression of geographic atrophy (GA) or, potentially, even reverse the retinal damage. The major categories include novel complement ...
KENTWOOD, Mich. (WOOD) — Long before the first bell rings at East Kentwood High School, music is already filling one of the building’s practice rooms. At 6:30 a.m., the ABC Orchestra stands in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results